Notably, sevoflurane treatment induces SESN2 expression in a p53-dependent fashion in human neuroblastoma M17 cells, and knockdown of SESN2 blunts superoxide activity, unleashing oxidative stress and apoptosis [88]. This evidence concerns the gene SESN2 and neuroblastoma.